Risk factor
High price volatility
Profitability factor
Favourable analyst view
About
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks.
Target Price
The average target price of SIBN is 25 and suggests 62% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell